References
- Adams, D. J., Jr, and I. N. Odunze. 1991. Oxygen free radicals and Parkinson’s disease. Free Radic. Biol. Med. 10:161–69. doi:https://doi.org/10.1016/0891-5849(91)90009-R.
- Ahmadi-Zeidabadi, M., Z. Akbarnejad, M. Esmaeeli, Y. Masoumi-Ardakani, L. Mohammadipoor-Ghasemabad, H. Eskandary. 2019. Impact of extremely low-frequency electromagnetic field (100 Hz, 100 G) exposure on human glioblastoma U87 cells during Temozolomide administration. Electromagn Biol. Med. 38:198–209. doi:https://doi.org/10.1080/15368378.2019.1625784.
- Akbari, A., and G.-A. Jelodar. 2013. The effect of oxidative stress and antioxidants on men fertility. Zahedan. J. Res. Med. Sci. 15:1–7.
- Akbarnejad, Z., H. Eskandary, L. Dini, C. Vergallo, S. N. Nematollahi-Mahani, A. Farsinejad, M. F. S. Abadi, M. Ahmadi. 2017. Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100 Hz, 100 G). Biomed. Pharmacother. 92:254–64. doi:https://doi.org/10.1016/j.biopha.2017.05.050.
- Aldrich, T. E., K. W. Andrews, and A. R. Liboff. 2001. Brain cancer risk and electromagnetic fields (EMFs): Assessing the geomagnetic component. Arch. Environ. Health 56:314–19. doi:https://doi.org/10.1080/00039890109604462.
- Alonso, M. M., C. Gomez-Manzano, B. N. Bekele, W. K. A. Yung, J. Fueyo. 2007. Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter. J. Cancer Res. 67:11499–504. doi:https://doi.org/10.1158/0008-5472.CAN-07-5312.
- Amiri, M., M. Basiri, H. Eskandary, Z. Akbarnejad, M. Esmaeeli, Y. Masoumi-Ardakani, M. Ahmadi-Zeidabadi. 2018. Cytotoxicity of carboplatin on human glioblastoma cells is reduced by the concomitant exposure to an extremely low-frequency electromagnetic field (50 Hz, 70 G). Electromagn Biol. Med. 37:138–45. doi:https://doi.org/10.1080/15368378.2018.1477052.
- Arsenijevic, D., H. Onuma, C. Pecqueur, S. Raimbault, B. S. Manning, B. Miroux, E. Couplan, M.-C. Alves-Guerra, M. Goubern, R. Surwit, et al. 2000. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat. Genet. 26:435. doi:https://doi.org/10.1038/82565.
- Baehner, R. L., L. A. Boxer, and J. Davis. 1976. The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes. Blood 48:309–13. doi:https://doi.org/10.1182/blood.V48.2.309.309.
- Berg, H., B. GÜnther, I. Hilger, M. Radeva, N. Traitcheva, L. Wollweber. 2010. Bioelectromagnetic field effects on cancer cells and mice tumors. Electromagn. Biol. Med. 29:132–43. doi:https://doi.org/10.3109/15368371003776725.
- Brix, G., E. A. Nekolla, D. Nosske, J. Griebel. 2009. Risks and safety aspects related to PET/MR examinations. Eur. J. Nucl. Med. Mol. Imaging 36:131–38. doi:https://doi.org/10.1007/s00259-008-0937-4.
- Cameron, I. L., M. S. Markov, and W. E. Hardman. 2014. Optimization of a therapeutic electromagnetic field (EMF) to retard breast cancer tumor growth and vascularity. Cancer Cell Int. 14:125. doi:https://doi.org/10.1186/s12935-014-0125-5.
- Cho, M. H., E. J. Lee, M. Son, J.-H. Lee, D. Yoo, J.-W. Kim, S. W. Park, J.-S. Shin, and J. Cheon. 2012. A magnetic switch for the control of cell death signalling in in vitro and in vivo systems. Nat. Mater 11:1038. doi:https://doi.org/10.1038/nmat3430.
- Ciejka, E., P. Kleniewska, B. Skibska, and A. Goraca. 2011. Effects of extremely low frequency magnetic field on oxidative balance in brain of rats. J. Physiol. Pharmacol. 62:657.
- D’Angelo, C., E. Costantini, M. Kamal, and M. Reale. 2015. Experimental model for ELF-EMF exposure: Concern for human health. Saudi J. Biol. Sci. 22:75–84. doi:https://doi.org/10.1016/j.sjbs.2014.07.006.
- Dini, L. 2010. Static magnetic field interferes with the physiological removal of circulating apoptotic lymphocytes. PIERS Online 6:252–56. doi:https://doi.org/10.2529/PIERS091005094213.
- Dini, L., and L. Abbro. 2005. Bioeffects of moderate-intensity static magnetic fields on cell cultures. Micron 36:195–217. doi:https://doi.org/10.1016/j.micron.2004.12.009.
- Dobson, J. 2008. Remote control of cellular behaviour with magnetic nanoparticles. Nat. Nanotechnol. 3:139. doi:https://doi.org/10.1038/nnano.2008.39.
- Falone, S., S. Santini, V. Cordone, P. Cesare, A. Bonfigli, M. Grannonico, G. Di Emidio, C. Tatone, M. Cacchio, F. Amicarelli, et al. 2017. Power frequency magnetic field promotes a more malignant phenotype in neuroblastoma cells via redox-related mechanisms. Sci. Rep. 7:11470. doi:https://doi.org/10.1038/s41598-017-11869-8.
- Filipovic, N., T. Djukic, M. Radovic, D. Cvetkovic, M. Curcic, S. Markovic, A. Peulic, and B. Jeremic. 2014. Electromagnetic field investigation on different cancer cell lines. Cancer Cell Int. 14:84. doi:https://doi.org/10.1186/s12935-014-0084-x.
- Funk, R. H., T. Monsees, and N. Özkucur. 2009. Electromagnetic effects–From cell biology to medicine. Prog. Histochem. Cytochem. 43:177–264. doi:https://doi.org/10.1016/j.proghi.2008.07.001.
- Furnari, F. B., T. Fenton, R. M. Bachoo, A. Mukasa, J. M. Stommel, A. Stegh, W. C. Hahn, K. L. Ligon, D. N. Louis, C. Brennan, et al. 2007. Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes Dev. 21:2683–710. doi:https://doi.org/10.1101/gad.1596707.
- Giacomelli, C., L. Natali, M. L. Trincavelli, S. Daniele, A. Bertoli, G. Flamini, A. Braca, and C. Martini. 2016. New insights into the anticancer activity of carnosol: P53 reactivation in the U87MG human glioblastoma cell line. Int. J. Biochem. Cell Biol. 74:95–108. doi:https://doi.org/10.1016/j.biocel.2016.02.019.
- Hofseth, L. J., S. P. Hussain, and C. C. Harris. 2004. p53: 25 years after its discovery. Trends Pharmacol. Sci. 25:177–81. doi:https://doi.org/10.1016/j.tips.2004.02.009.
- Huang, L., L. Dong, Y. Chen, H. Qi, and D. Xiao. 2006. Effects of sinusoidal magnetic field observed on cell proliferation, ion concentration, and osmolarity in two human cancer cell lines. Electromagn Biol. Med. 25:113–26. doi:https://doi.org/10.1080/15368370600719067.
- Kanzawa, T., J. Bedwell, Y. Kondo, S. Kondo, and I. M. Germano. 2003. Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide. J. Neurosurg. 99:1047–52. doi:https://doi.org/10.3171/jns.2003.99.6.1047.
- Kiseleva, L., A. Kartashev, N. Vartanyan, A. A. Pinevich, and M. P. Samoilovich. 2016. CHARACTERISTICS OF A172 AND T98G CELL LINES. Tsitologiia 58:349–55.
- Klautke, G., M. Schütze, I. Bombor, R. Benecke, J. Piek, and R. Fietkau. 2006. Concurrent chemoradiotherapy and adjuvant chemotherapy with Topotecan for patients with glioblastoma multiforme. J. Neuro-Oncol. 77:199–205. doi:https://doi.org/10.1007/s11060-005-9028-6.
- Lockwich, T. P., X. Liu, B. B. Singh, J. Jadlowiec, S. Weiland, and I. S. Ambudkar. 2000. Assembly of Trp1 in a signaling complex associated with caveolin-scaffolding lipid raft domains. J. Biol. Chem. 275:11934–42. doi:https://doi.org/10.1074/jbc.275.16.11934.
- Miyakoshi, J. 2005. Effects of static magnetic fields at the cellular level. Prog. Biophys. Mol. Biol. 87:213–23. doi:https://doi.org/10.1016/j.pbiomolbio.2004.08.008.
- Moreira, M. E. C., and M. A. Barcinski. 2004. Apoptotic cell and phagocyte interplay: Recognition and consequences in different cell systems. An. Acad. Bras. Cienc. 76:93–115. doi:https://doi.org/10.1590/S0001-37652004000100009.
- Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55–63. doi:https://doi.org/10.1016/0022-1759(83)90303-4.
- Munoz, J. L., V. Rodriguez-Cruz, N. D. Walker, S. J. Greco, and P. Rameshwar. 2015. Temozolomide resistance and tumor recurrence: Halting the Hedgehog. Cancer Cell & Microenv 2.
- Naganuma, H., E. Satoh, T. Kawataki, Satoh, H. and Nukui, H.. 2003. Cell density regulates thrombospondin-1 production in malignant glioma cells. Neuro Oncol 63:147–53. doi:https://doi.org/10.1023/A:1023927417433.
- Nie, E., X. Jin, W. Wu, T. Yu, X. Zhou, T. Zhi, Z. Shi, J. Zhang, N. Liu, Y. You, et al. 2016. BACH1 promotes temozolomide resistance in glioblastoma through antagonizing the function of p53. Sci. Rep. 6:39743. doi:https://doi.org/10.1038/srep39743.
- O’Brien, V., and R. Brown. 2005. Signalling cell cycle arrest and cell death through the MMR System. Carcinogenesis 27:682–92. doi:https://doi.org/10.1093/carcin/bgi298.
- Ostrom, Q. T., H. Gittleman, J. Fulop, M. Liu, R. Blanda, C. Kromer, Y. Wolinsky, C. Kruchko, and J. S. Barnholtz-Sloan. 2015. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro. Oncol. 17:iv1–iv62. doi:https://doi.org/10.1093/neuonc/nov189.
- Pacini, S., G. B. Vannelli, T. Barni, M. Ruggiero, I. Sardi, P. Pacini, and M. Gulisano. 1999. Effect of 0.2 T static magnetic field on human neurons: Remodeling and inhibition of signal transduction without genome instability. Neurosci. Lett. 267:185–88. doi:https://doi.org/10.1016/S0304-3940(99)00362-6.
- Panagopoulos, D. J., L. H. Margaritis, A. A. Pilla, and A. Liboff. 2003. Mechanisms of action of emfs on biological systems in biological effects of electromagnetic fields, 4–113. Berlin, Heidelberg: Springer.
- Pazur, A., C. Schimek, and P. Galland. 2007. Magnetoreception in microorganisms and fungi. Open Life Sci 2:597–659. doi:https://doi.org/10.2478/s11535-007-0032-z.
- Qin, S., H. Yin, C. Yang, Y. Dou, Z. Liu, P. Zhang, H. Yu, Y. Huang, J. Feng, J. Hao, et al. 2016. A magnetic protein biocompass. Nat. Mater. 15:217. doi:https://doi.org/10.1038/nmat4484.
- Reyes-Guerrero, G., C. Guzmán, D. E. García, I. Camacho-Arroyo, and M. Vázquez-García. 2010. Extremely low-frequency electromagnetic fields differentially regulate estrogen receptor-α and -β expression in the rat olfactory bulb. Neurosci. Lett. 471:109–13. doi:https://doi.org/10.1016/j.neulet.2010.01.021.
- Robison, J. G., A. R. Pendleton, K. O. Monson, B. K. Murray, and K. L. O’Neill. 2002. Decreased DNA repair rates and protection from heat induced apoptosis mediated by electromagnetic field exposure. Bioelectromagnetics 23:106–12. doi:https://doi.org/10.1002/bem.103.
- Rollwitz, J., M. Lupke, and M. Simkó. 2004. Fifty-hertz magnetic fields induce free radical formation in mouse bone marrow-derived promonocytes and macrophages. Biochim. Biophys. Acta 1674:231–38. doi:https://doi.org/10.1016/j.bbagen.2004.06.024.
- Ronchetto, F., D. Barone, M. Cintorino, M. Berardelli, S. Lissolo, R. Orlassino, P. Ossola, and S. Tofani. 2004. Extremely low frequency‐modulated static magnetic fields to treat cancer: A pilot study on patients with advanced neoplasm to assess safety and acute toxicity. Bioelectromagnetics 25:563–71. doi:https://doi.org/10.1002/bem.20029.
- Rosen, A. D. 2003. Mechanism of action of moderate-intensity static magnetic fields on biological systems. Cell Biochem. Biophys 39:163–73. doi:https://doi.org/10.1385/CBB:39:2:163.
- Ruiz‐Gómez, M., L. De la Peña, M. Prieto‐Barcia, J. M. Pastor, L. Gil, and M. Martínez-Morillo. 2002. Influence of 1 and 25 Hz, 1.5 mT magnetic fields on antitumor drug potency in a human adenocarcinoma cell line. Bioelectromagnetics 23:578–525. doi:https://doi.org/10.1002/bem.10054.
- Ruiz-Gómez, M. J., and M. Martínez-Morillo. 2009. Electromagnetic fields and the induction of DNA strand breaks. Electromagn. Biol. Med. 28:201–14. doi:https://doi.org/10.1080/15368370802608696.
- Sahebjamei, H., P. Abdolmaleki, and F. Ghanati. 2007. Effects of magnetic field on the antioxidant enzyme activities of suspension‐cultured tobacco cells. Bioelectromagnetics: Journal of the Bioelectromagnetics 28:42–47. doi:https://doi.org/10.1002/bem.20262.
- Saunders, R. 2005. Static magnetic fields: Animal studies. Prog. Biophys. Mol. Biol. 87:225–39. doi:https://doi.org/10.1016/j.pbiomolbio.2004.09.001.
- Schenck, J. F. 1996. The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med. Phys 23:815–50. doi:https://doi.org/10.1118/1.597854.
- Schenck, J. F. 2005. Physical interactions of static magnetic fields with living tissues. Prog. Biophys. Mol. Biol. 87:185–204. doi:https://doi.org/10.1016/j.pbiomolbio.2004.08.009.
- Simkó, M., and M. O. Mattsson. 2004. Extremely low frequency electromagnetic fields as effectors of cellular responses in vitro: Possible immune cell activation. J. Cell. Biochem. 93:83–92. doi:https://doi.org/10.1002/jcb.20198.
- Sladowski, D., S. J. Steer, R. H. Clothier, and M. Balls. 1993. An improved MIT assay. J. Immunol. Methods 157:203–07. doi:https://doi.org/10.1016/0022-1759(93)90088-O.
- Stupp, R., P.-Y. Dietrich, S. O. Kraljevic, A. Pica, I. Maillard, P. Maeder, R. Meuli, R. Janzer, G. Pizzolato, R. Miralbell, et al. 2002. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J. Clin. Oncol. 20:1375–82. doi:https://doi.org/10.1200/JCO.2002.20.5.1375.
- Stupp, R., W. P. Mason, M. J. Van Den Bent, M. Weller, B. Fisher, M. J. B. Taphoorn, K. Belanger, A. A. Brandes, C. Marosi, U. Bogdahn, et al. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352:987–96. doi:https://doi.org/10.1056/NEJMoa043330.
- Tatar, Z., E. Thivat, E. Planchat, P. Gimbergues, E. Gadea, C. Abrial, and X. Durando. 2013. Temozolomide and unusual indications: Review of literature. Cancer Treat. Rev 39:125–35. doi:https://doi.org/10.1016/j.ctrv.2012.06.002.
- Tatarov, I., A. Panda, D. Petkov, K. Kolappaswamy, K. Thompson, A. Kavirayani, M. M. Lipsky, E. Elson, C. C. Davis, S. S. Martin, et al. 2011. Effect of magnetic fields on tumor growth and viability. Comp. Med 61:339–45.
- Tawbin, H., T. Stahelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Proc Not 4350–54. doi:https://doi.org/10.1073/pnas.76.9.4350.
- Tenuzzo, B., C. Vergallo, and L. Dini. 2009. Effect of 6 mT static magnetic field on the bcl-2, bax, p53 and hsp70 expression in freshly isolated and in vitro aged human lymphocytes. Tissue Cell 41:169–79. doi:https://doi.org/10.1016/j.tice.2008.09.004.
- Tofani, S., D. Barone, M. Berardelli, Berno, E., Cintorino, M., Foglia, L., Ossola, P, et al. 2003. Static and ELF magnetic fields enhance the in vivo anti-tumor efficacy of cis-platin against lewis lung carcinoma, but not of cyclophosphamide against B16 melanotic melanoma. Pharmacol. Res. Commun. 48:83–90.
- Tofani, S., M. Cintorino, D. Barone, M. Berardelli, M. M. De Santi, A. Ferrara, R. Orlassino, P. Ossola, K. Rolfo, F. Ronchetto, et al. 2002. Increased mouse survival, tumor growth inhibition and decreased immunoreactive p53 after exposure to magnetic fields. Bioelectromagnetics 23:230–38. doi:https://doi.org/10.1002/bem.10010.
- Vassilev, P. M., R. T. Dronzine, M. P. Vassileva, and G. A. Georgiev. 1982. Parallel arrays of microtubules formed in electric and magnetic fields. Biosci. Rep. 2:1025–29. doi:https://doi.org/10.1007/BF01122171.
- Wolf, F. I., A. Torsello, B. Tedesco, S. Fasanella, A. Boninsegna, M. D’Ascenzo, C. Grassi, G. B. Azzena, and A. Cittadini. 2005. 50-Hz extremely low frequency electromagnetic fields enhance cell proliferation and DNA damage: Possible involvement of a redox mechanism. Biochim. Biophys. Acta 1743:120–29. doi:https://doi.org/10.1016/j.bbamcr.2004.09.005.
- Yang, M., and Z. Ye. 2015. Extremely low frequency electromagnetic field induces apoptosis of osteosarcoma cells via oxidative stress. J. Zhejiang Univ. Sci. B 44:323–28.
- Zhou, S.-A., and M. Uesaka. 2006. Bioelectrodynamics in living organisms. Int. J. Eng. Sci. 44:67–92. doi:https://doi.org/10.1016/j.ijengsci.2005.11.001.